For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251211:nRSK2654La&default-theme=true
RNS Number : 2654L Bank of Montreal 11 December 2025
Regulatory Announcement
RNS Number: 2564L
Bank of Montreal
December 11, 2025
The following supplement has been approved by the Financial Conduct Authority
and is available for viewing:
2(nd) Supplement dated December 11, 2025 relating to the U.S.$40,000,000,000
Note Issuance Programme of Bank of Montreal.
The 2(nd) Supplement and the documents incorporated by reference therein have
been submitted to the National Storage Mechanism and will shortly be available
for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus dated June 27,
2025, as supplemented by the 1(st) Supplement dated August 26, 2025 and the
2(nd) Supplement dated December 11, 2025 (together, the "Prospectus"), may be
addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the Prospectus is not addressed. Prior to relying on
the information contained in the Prospectus you must ascertain from the
Prospectus whether or not you are part of the intended addressees of the
information contained therein.
The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the United States and are subject to United States tax
law requirements. Subject to certain exceptions, the Notes may not be
offered, sold or delivered, directly or indirectly, in the United States or to
or for the account or benefit of a "U.S. person" (as defined in Regulation S
under the Securities Act). No public offering of the Notes is being made in
the United States. This announcement does not constitute an offer to sell or a
solicitation to buy securities in the United States or in any other
jurisdiction where such offer or solicitation would be unlawful.
Your right to access this service is conditional upon complying with the above
requirement.
To view the full document, please paste the following URLs into the address
bar of your browser:
2(nd) Supplement dated December 11, 2025
http://www.rns-pdf.londonstockexchange.com/rns/2654L_3-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2654L_3-2025-12-11.pdf)
Documents Incorporated by Reference
2025 Annual Information Form dated December 4, 2025
http://www.rns-pdf.londonstockexchange.com/rns/2654L_1-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2654L_1-2025-12-11.pdf)
2025 Annual Report
http://www.rns-pdf.londonstockexchange.com/rns/2654L_2-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2654L_2-2025-12-11.pdf)
For further information, please contact:
Zoë Kruis
Corporate Secretary's Dept.
Phone: (437) 775-8791
Email: zoe.kruis@bmo.com (mailto:zoe.kruis@bmo.com)
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PDIFFLFMFEISESE
Copyright 2019 Regulatory News Service, all rights reserved